期刊
CLINICAL NUCLEAR MEDICINE
卷 39, 期 7, 页码 E365-E366出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000238
关键词
PET; FDG; natalizumab; progressive multifocal leukoencephalopathy; PML